Sadly, a common pattern to export bad product and business methods to other, often more vulnerable countries. This is a follow up to LA Times' great reporting

Sadly, a common pattern to export bad product and business methods to other, often more vulnerable countries. This is a follow up to LA Times' great reporting on OxyContin back in May, which uncovered how opioid addiction has exploded due to false representation of oxycontin's effectiveness, which was done to justify the more expensive patented time release mechanism of their pill. http://www.latimes.com/projects/oxycontin-part1/ http://www.latimes.com/projects/oxycontin-part1/